Immediate Impact

4 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
2023 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
1 intermediate paper

Works of M Takada being referenced

Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation
1998
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
1994

Author Peers

Author Last Decade Papers Cites
M Takada 642 451 361 59 1.0k
Mitsumasa Ogawara 565 504 253 50 1.0k
Nae Choon Yoo 397 240 309 53 949
P C Hoffman 539 560 143 46 957
Olaf Neth 324 146 259 52 1.3k
Gen Yamada 191 618 315 90 1.2k
Eleni Karapanagiotou 582 280 443 65 1.3k
Thomas Hager 363 510 320 68 1.1k
Diane Brown 320 174 179 40 1.2k
Toshihiro Suzuki 474 154 382 82 1.2k
Takashi Kasai 406 425 325 56 871

All Works

Loading papers...

Rankless by CCL
2026